Results 101 to 110 of about 20,741 (247)
Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods
Journal of Medical Virology, Volume 97, Issue 2, February 2025.ABSTRACT Hepatitis C virus infection is a significant global health concern, affecting millions worldwide. Although direct‐acting antivirals achieve over 90% success rate, treatment failures still occur, particularly when pan‐genotypic DAAs are unavailable, and drugs need to be chosen based on the present HCV genotype.
Nurhan Arslan +6 more
wiley +1 more source
Chronic equine hepacivirus infection in an adult gelding with severe hepatopathy [PDF]
Veterinary Medicine and Science, 2019 AbstractBackground: Equine hepacivirus (EqHV) in equids represents the closest homologue to hepatitis C virus (HCV) infecting humans. A majority ofHCVinfected patients develop a chronic course of infection leading to liver fibrosis, cirrhosis and liver failure. However, in horses mostly transient mild subclinical infections are reported for EqHVto date.
Birthe Tegtmeyer +10 more
openaire +4 more sources
First report of equine parvovirus-hepatitis and equine hepacivirus co-infection in horses in Korea.
Transboundary and Emerging Diseases, 2021 Equine parvovirus-hepatitis (EqPV-H) and equine hepacivirus (EqHV) are etiologically associated with Theiler's disease (TD), causing fulminant equine hepatitis, but the transmission route and co-infection effect remain unclear.
Jungho Yoon +12 more
semanticscholar +1 more source
ACR Open Rheumatology, Volume 7, Issue 1, January 2025.Objective Idiopathic inflammatory myopathies (IIMs) are a group of heterogeneous, systemic autoimmune diseases characterized by specific clinical features and, frequently, skeletal muscle inflammation. Specific subtypes of IIMs can be characterized by myositis‐specific autoantibodies and are associated with distinct clinical phenotypes.
Sahana Jayaraman +5 more
wiley +1 more source
HepacivirusInfection in Domestic Horses, Brazil, 2011–2013
Emerging Infectious Diseases, 2014 To the Editor: An estimated ≈150 million persons (3% of the world population) are chronically infected with hepatitis C virus (HCV). This virus is the prototype of the genus Hepacivirus and a major cause of liver cirrhosis and hepatocellular carcinoma around the world.
Max Moreira Alves +13 more
openaire +4 more sources
Gut and Liver, 2017 Background/AimsThe approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV).Methods : We assessed the sustained virological response (SVR) of SOF-based regimens in a real-world single ...
Hyun Phil Shin +8 more
doaj +1 more source
Human platelets and their capacity of binding viruses: Meaning and challenges? [PDF]
, 2015 Blood platelets are first aimed at ensuring primary hemostasis. Beyond this role, they have been acknowledged as having functions in the maintenance of the vascular arborescence and, more recently, as being also innate immune cells, devoted notably to ...
Chabert, Adrien +6 more
core +2 more sources
Gut and Liver, 2017 Background/AimsThe association between depression and chronic hepatitis C virus (HCV) infection or pegylated interferon α and ribavirin therapy (PR therapy) has not been extensively studied in Korea.
Joo Yeong Baeg +9 more
doaj +1 more source
Advances in Virology, Volume 2025, Issue 1, 2025.Hepatitis C virus (HCV) is implicated in carcinogenic infections like hepatocellular carcinoma (HCC). Given that no HCV vaccine is currently available, comprehensive epidemiological understanding is crucial for devising effective prevention strategies.
Samia Boukaira +6 more
wiley +1 more source
Gut and Liver, 2017 Background/AimsTo evaluate the era of direct acting antivirals (DAAs), we must understand the treatment patterns and outcomes of interferon-based therapy for hepatitis C virus (HCV) infection.
Eun Sun Jang +7 more
doaj +1 more source